Oral manifestations after vaccinations: A systematic review of observational studies.
adverse effects
case reports
case series
oral mucosa
vaccine
Journal
Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565
Informations de publication
Date de publication:
06 Feb 2024
06 Feb 2024
Historique:
revised:
16
01
2024
received:
31
07
2023
accepted:
19
01
2024
medline:
7
2
2024
pubmed:
7
2
2024
entrez:
6
2
2024
Statut:
aheadofprint
Résumé
This study aimed to assess the prevalence and types of oral adverse events following immunization (AEFIs) in people who received at least one dose of any type of vaccine. We conducted a bibliographic search about oral AEFIs in MEDLINE, Embase, PubMed, and Ovid from database inception to November 07, 2022. Risk of bias was assessed using the MURAD or the Quality In Prognosis Studies tools. Random-effects proportional meta-analysis was applied. A total of 119 studies involving 343 people were eligible. These reported AEFIs occurred following administration of the coronavirus disease 2019 vaccine, anti-influenza vaccine, hepatitis B vaccine, and anti-smallpox vaccine. The most common to be affected in vaccinated people were buccal mucosa (63.1%; 95% confidence interval (CI) 33.4-88.2) and lips (55.7%; 95% CI, 41.1-69.8). The most prevalent oral AEFIs were ulceration (55.2%; 95% CI 24.4-84.0), swelling (65.2%; 95% CI 34.9-89.8), and burning sensation (18.3%; 95% CI 7.9-31.8). The mechanisms underlying oral AEFIs should be further investigated to promptly recognize oral manifestations and provide optimal management for people undergoing vaccination.
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Akanmori, B. D., Traore, T., Balakrishnan, M., Maure, C., Zuber, P., & Mihigo, R. (2018). Vaccine safety and pharmacovigilance in the African region: Recent updates. Journal of Immunological Sciences, 2, 80-88.
Arduino, P. G., Kubanov, A. A., Vlasova, A. V., Martynov, A. A., Svishchenko, S. I., & Petti, S. (2024). De novo pemphigus vulgaris and pemphigus foliaceus development following COVID-19 infection and vaccination: Matched case-control study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19783. Online ahead of print.
Avallone, G., Quaglino, P., Cavallo, F., Roccuzzo, G., Ribero, S., Zalaudek, I., & Conforti, C. (2022). SARS-CoV-2 vaccine-related cutaneous manifestations: A systematic review. International Journal of Dermatology, 61(10), 1187-1204. https://doi.org/10.1111/ijd.16063
Caggiano, M., Amato, M., Di Spirito, F., Galdi, M., & Sisalli, L. (2022). mRNA COVID-19 vaccine and oral lichen planus: A case report. Oral Diseases, 28, 2624-2626. https://doi.org/10.1111/odi.14184
Cascone, M., Celentano, A., Adamo, D., Leuci, S., Ruoppo, E., & Mignogna, M. D. (2017). Oral lichen planus in childhood: A case series. International Journal of Dermatology, 56(6), 641-652. https://doi.org/10.1111/ijd.13571
Cirillo, N. (2021). Reported orofacial adverse effects of COVID-19 vaccines: The knowns and the unknowns. Journal of Oral Pathology & Medicine, 50(4), 424-427. https://doi.org/10.1111/jop.13165
Danova, J., Kocourkova, A., & Celko, A. M. (2017). Active surveillance study of adverse events following immunisation of children in the Czech Republic. BMC Public Health, 17(1), 167. https://doi.org/10.1186/s12889-017-4083-4
Davis, R. L., Kolczak, M., Lewis, E., Nordin, J., Goodman, M., Shay, D. K., Platt, R., Black, S., Shinefield, H., & Chen, R. T. (2005). Active surveillance of vaccine safety: A system to detect early signs of adverse events. Epidemiology, 16(3), 336-341. https://doi.org/10.1097/01.ede.0000155506.05636.a4
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177-188.
Di Spirito, F., Contaldo, M., Amato, A., Di Palo, M. P., Pantaleo, G., & Amato, M. (2022). COVID-19 vaccine and oral lesions: Putative pathogenic mechanisms. Oral Diseases, 28 Suppl 2, 2639-2640. https://doi.org/10.1111/odi.14361
Di Spirito, F., D'Ambrosio, F., Di Palo, M. P., Giordano, F., Coppola, N., & Contaldo, M. (2023). COVID-19 and related vaccinations in children: Pathogenic aspects of Oral lesions. Children (Basel), 10(5), 809. https://doi.org/10.3390/children10050809
Duclos, P. (2003). Safety of immunisation and adverse events following vaccination against hepatitis B. Expert Opinion on Drug Safety, 2(3), 225-231. https://doi.org/10.1517/14740338.2.3.225
Freeman, M. F., & Tukey, J. W. (1950). Transformations related to the angular and the square root. The Annals of Mathematical Statistics, 21(4), 607-611.
Fritsche, P. J., Helbling, A., & Ballmer-Weber, B. K. (2010). Vaccine hypersensitivity-Update and overview. Swiss Medical Weekly, 140(17-18), 238-246. https://doi.org/10.4414/smw.2010.12980
Gerberding, J. L., & Haynes, B. F. (2021). Vaccine innovations - past and future. The New England Journal of Medicine, 384(5), 393-396. https://doi.org/10.1056/NEJMp2029466
Goriely, S., & Goldman, M. (2007). From tolerance to autoimmunity: Is there a risk in early life vaccination? Journal of Comparative Pathology, 137(Suppl 1), S57-S61. https://doi.org/10.1016/j.jcpa.2007.04.013
Hayden, J. A., van der Windt, D. A., Cartwright, J. L., Côté, P., & Bombardier, C. (2013). Assessing bias in studies of prognostic factors. Annals of Internal Medicine, 158(4), 280-286. https://doi.org/10.7326/0003-4819-158-4-201302190-00009
Herzum, A., Burlando, M., Molle, M. F., Micalizzi, C., Cozzani, E., & Parodi, A. (2021). Lichen planus flare following COVID-19 vaccination: A case report. Clinical Case Reports, 9(12), e05092. https://doi.org/10.1002/ccr3.5092
Hibbs, B. F., Ng, C. S., Museru, O., Moro, P. L., Marquez, P., Woo, E. J., Cano, M. V., & Shimabukuro, T. T. (2020). Reports of atypical shoulder pain and dysfunction following inactivated influenza vaccine, vaccine adverse event reporting system (VAERS), 2010-2017. Vaccine, 38(5), 1137-1143. https://doi.org/10.1016/j.vaccine.2019.11.023
Hill, A. B. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58(5), 295-300.
Katsikas Triantafyllidis, K., Giannos, P., Mian, I. T., Kyrtsonis, G., & Kechagias, K. S. (2021). Varicella zoster virus reactivation following COVID-19 vaccination: A systematic review of case reports. Vaccines (Basel), 9(9), 1013. https://doi.org/10.3390/vaccines9091013
Kulkarni, R., & Sollecito, T. P. (2021). COVID-19 vaccination: Possible short-term exacerbations of oral mucosal diseases. International Journal of Dermatology, 60(9), e335-e336. https://doi.org/10.1111/ijd.15779
Mazur, M., Duś-Ilnicka, I., Jedliński, M., Ndokaj, A., Janiszewska-Olszowska, J., Ardan, R., Radwan-Oczko, M., Guerra, F., Luzzi, V., Vozza, I., Marasca, R., Ottolenghi, L., & Polimeni, A. (2021). Facial and oral manifestations following COVID-19 vaccination: A survey-based study and a first perspective. International Journal of Environmental Research and Public Health, 18(9), 4965. https://doi.org/10.3390/ijerph18094965
McMahon, D. E., Amerson, E., Rosenbach, M., Lipoff, J. B., Moustafa, D., Tyagi, A., Desai, S. R., French, L. E., Lim, H. W., Thiers, B. H., Hruza, G. J., Blumenthal, K. G., Fox, L. P., & Freeman, E. E. (2021). Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. Journal of the American Academy of Dermatology, 85(1), 46-55. https://doi.org/10.1016/j.jaad.2021.03.092
MedCalc. (2022). MedCalc Statistical Software version 20.210, Ostend, Belgium.
Miller, E. R., Moro, P. L., Cano, M., & Shimabukuro, T. T. (2015). Deaths following vaccination: What does the evidence show? Vaccine, 33(29), 3288-3292. https://doi.org/10.1016/j.vaccine.2015.05.023
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. International Journal of Surgery, 8(5), 336-341. https://doi.org/10.1016/j.ijsu.2010.02.007
Murad, M. H., Sultan, S., Haffar, S., & Bazerbachi, F. (2018). Methodological quality and synthesis of case series and case reports. BMJ Evidence-Based Medicine, 23(2), 60-63. https://doi.org/10.1136/bmjebm-2017-110853
Nalca, A., & Zumbrun, E. E. (2010). ACAM2000: The new smallpox vaccine for United States strategic National Stockpile. Drug Design, Development and Therapy, 4, 71-79. https://doi.org/10.2147/dddt.s3687
Peng, B., Che, D., Hao, Y., Zheng, Y., Liu, R., Qian, Y., Cao, J., Wang, J., Zhang, Y., He, L., & Geng, S. (2019). Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2. Journal of Dermatological Science, 95(3), 99-106. https://doi.org/10.1016/j.jdermsci.2019.07.007
Petti, S., & Arduino, P. G. (2023). New-onset pemphigus vulgaris and pemphigus foliaceus following COVID-19 infection and vaccination, systematic review of case reports and a causal hypothesis. Journal of the European Academy of Dermatology and Venereology, 37(11), e1256-e1260. https://doi.org/10.1111/jdv.19271
Pettoello-Mantovani, M., Cardemil, C., Cohen, R., Levy, C., Giardino, I., Indrio, F., & Somekh, E. (2022). Importance of coronavirus disease 2019 vaccination in children: Viewpoint and recommendations of the Union of European National Societies of Pediatrics. The Journal of Pediatrics, 243, 242-245. https://doi.org/10.1016/j.jpeds.2021.12.066
Riad, A. (2021). Oral side effects of COVID-19 vaccine. British Dental Journal, 230(2), 59. https://doi.org/10.1038/s41415-021-2615-x
Rosenblatt, A. E., & Stein, S. L. (2015). Cutaneous reactions to vaccinations. Clinics in Dermatology, 33(3), 327-332. https://doi.org/10.1016/j.clindermatol.2014.12.009
Shafie'ei, M., Jamali, M., Akbari, Z., Sarvipour, N., Ahmadzade, M., & Ahramiyanpour, N. (2022). Cutaneous adverse reactions following COVID-19 vaccinations: A systematic review and meta-analysis. Journal of Cosmetic Dermatology, 21(9), 3636-3650. https://doi.org/10.1111/jocd.15261
Shikha, G. S., Mahajan, A., Ambika, G. R., & Ghosh, S. (2022). Childhood oral lichen planus: A case series with review of literature. European Archives of Paediatric Dentistry, 23(2), 341-353. https://doi.org/10.1007/s40368-021-00690-7
Sun, Q., Fathy, R., McMahon, D. E., & Freeman, E. E. (2021). COVID-19 vaccines and the skin: The landscape of cutaneous vaccine reactions worldwide. Dermatologic Clinics, 39(4), 653-673. https://doi.org/10.1016/j.det.2021.05.016
Talotta, R. (2021). Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”. Clinical Immunology, 224, 108665. https://doi.org/10.1016/j.clim.2021.108665
Tarakji, B., Ashok, N., Alakeel, R., Azzeghaibi, S., Umair, A., Darwish, S., Mahmoud, R., & Elkhatat, E. (2014). Hepatitis B vaccination and associated oral manifestations: A non-systematic review of literature and case reports. Annals of Medical and Health Sciences Research, 4(6), 829-836. https://doi.org/10.4103/2141-9248.144870
Wang, C., Huang, N., Lu, Q. B., Black, S., Liang, X., & Cui, F. (2022). Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China. Frontiers in Immunology, 13, 956473. https://doi.org/10.3389/fimmu.2022.956473
Wichova, H., Miller, M. E., & Derebery, M. J. (2021). Otologic manifestations after COVID-19 vaccination: The house ear clinic experience. Otology & Neurotology, 42(9), e1213-e1218. https://doi.org/10.1097/mao.0000000000003275
World Health Organization. (2019). Causality assessment of an adverse event following immunization (AEFI): User manual for the revised who classification (2nd ed.). World Health Organization.
World Health Organization. Regional Office for the Western, P. (2016). Immunization safety surveillance: Guidelines for immunization programme managers on surveillance of adverse events following immunization (3rd ed.). WHO Regional Office for the Western Pacific.